The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial

por Seebacher, V, Polterauer, S, Grimm, C, Husslein, H, Leipold, H, Hefler-Frischmuth, K, Tempfer, C, Reinthaller, A, Hefler, L
Publicado 2010

High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer

por Berthier, A, Seguin, S, Sasco, A J, Bobin, J Y, De Laroche, G, Datchary, J, Saez, S, Rodriguez-Lafrasse, C, Tolle, F, Fraichard, A, Boyer-Guittaut, M, Jouvenot, M, Delage-Mourroux, R, Descotes, F
Publicado 2010

Identification of DBC1 as a transcriptional repressor for BRCA1

por Hiraike, H, Wada-Hiraike, O, Nakagawa, S, Koyama, S, Miyamoto, Y, Sone, K, Tanikawa, M, Tsuruga, T, Nagasaka, K, Matsumoto, Y, Oda, K, Shoji, K, Fukuhara, H, Saji, S, Nakagawa, K, Kato, S, Yano, T, Taketani, Y
Publicado 2010

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

por Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L
Publicado 2010

Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer

por Koumakpayi, I H, Le Page, C, Mes-Masson, A-M, Saad, F
Publicado 2010

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis

por Walsh, N, Kennedy, S, Larkin, A M, Tryfonopoulos, D, Eustace, A J, Mahgoub, T, Conway, C, Oglesby, I, Collins, D, Ballot, J, Ooi, W S, Gullo, G, Clynes, M, Crown, J, O'Driscoll, L
Publicado 2010

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

por Coleman, R E, Winter, M C, Cameron, D, Bell, R, Dodwell, D, Keane, M M, Gil, M, Ritchie, D, Passos-Coelho, J L, Wheatley, D, Burkinshaw, R, Marshall, S J, Thorpe, H
Publicado 2010

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

por Northover, J, Glynne-Jones, R, Sebag-Montefiore, D, James, R, Meadows, H, Wan, S, Jitlal, M, Ledermann, J
Publicado 2010

Circulating microRNAs in plasma of patients with gastric cancers

por Tsujiura, M, Ichikawa, D, Komatsu, S, Shiozaki, A, Takeshita, H, Kosuga, T, Konishi, H, Morimura, R, Deguchi, K, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2010

Cancer screening and preventative care among long-term cancer survivors in the United Kingdom

por Khan, N F, Carpenter, L, Watson, E, Rose, P W
Publicado 2010

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

por Daayana, S, Elkord, E, Winters, U, Pawlita, M, Roden, R, Stern, P L, Kitchener, H C
Publicado 2010

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery

por Fang, D D, Kim, Y J, Lee, C N, Aggarwal, S, McKinnon, K, Mesmer, D, Norton, J, Birse, C E, He, T, Ruben, S M, Moore, P A
Publicado 2010

Predicting the risk of endometrial cancer in postmenopausal women presenting with vaginal bleeding: the Norwich DEFAB risk assessment tool

por Burbos, N, Musonda, P, Giarenis, I, Shiner, A M, Giamougiannis, P, Morris, E P, Nieto, J J
Publicado 2010

Determinants of survival in patients with brain metastases from cutaneous melanoma

por Staudt, M, Lasithiotakis, K, Leiter, U, Meier, F, Eigentler, T, Bamberg, M, Tatagiba, M, Brossart, P, Garbe, C
Publicado 2010

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

por Penel, N, Clisant, S, Dansin, E, Desauw, C, Dégardin, M, Mortier, L, Vanhuyse, M, Bonodeau, F, Fournier, C, Cazin, J-L, Adenis, A
Publicado 2010

Common germ-line polymorphism of C1QA and breast cancer survival

por Azzato, E M, Lee, A J X, Teschendorff, A, Ponder, B A J, Pharoah, P, Caldas, C, Maia, A T
Publicado 2010

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa

por de Bruijn, M T, Raats, D A E, Hoogwater, F J H, van Houdt, W J, Cameron, K, Medema, J P, Borel Rinkes, I H M, Kranenburg, O
Publicado 2010

EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy

por Evans, A H, Pancholi, S, Farmer, I, Thornhill, A, Evans, D B, Johnston, S R, Dowsett, M, Martin, L-A
Publicado 2010

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

por Matthay, K K, Shulkin, B, Ladenstein, R, Michon, J, Giammarile, F, Lewington, V, Pearson, A D J, Cohn, S L
Publicado 2010

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer

por Lee, C K, Stockler, M R, Coates, A S, Gebski, V, Lord, S J, Simes, R J
Publicado 2010